The Dancing Nurse: Addressing Barriers To The Implementation Of Movement-Based Interventions In Holistic Patient Care, 2018 Oral Roberts University
The Dancing Nurse: Addressing Barriers To The Implementation Of Movement-Based Interventions In Holistic Patient Care, Jessica Collier, Audrey Thompson Phd
Nursing Undergraduate Work
The efficacy of dance movement therapy (DMT) is well demonstrated in contemporary nursing literature; however, implementation by healthcare professionals is often limited. Dance movement therapy was pioneered in the mid-20th century by classically trained modern dancer Marian Chace. Recent trends toward patient-centered care and interdisciplinary approaches render therapies such as DMT important modalities which nurses and other healthcare providers may become familiar with. This systematic research review focused on answering the question: “what are hindrances perceived by members of the healthcare team to implementing DMT as an alternative treatment modality?” Two variables were identified for the purposes of this ...
Transitioning To The Role Of A Professional Physical Therapist Through Community Engagement, 2018 Virginia Wesleyan College
Transitioning To The Role Of A Professional Physical Therapist Through Community Engagement, Brittany L. Wentzel
VA Engage Journal
This article recounts the author's experiences observing and interning with physical therapists in a variety of settings.The hands-on experiences the author describes allowed the author to learn the specific procedures and requirements in a typical day as a Physical Therapist, and to gain knowledge on the protocol for different injuries, the muscles that each exercise strengthens, and how to properly perform exercises to prevent further injuries. The author also explores how these experiences fostered observational and interpersonal skills and solidified the decision to pursue Physical Therapy as a career.
A Delayed Diagnosis Of Tarsometatarsal Ligament (Lisfranc) Sprain In A Female College Soccer Athlete And Foot Rehabilitation, 2018 University of Nebraska at Omaha
A Delayed Diagnosis Of Tarsometatarsal Ligament (Lisfranc) Sprain In A Female College Soccer Athlete And Foot Rehabilitation, Boyoung Park
Student Research and Creative Activity Fair
A Delayed Diagnosis of Tarsometatarsal Ligament (Lisfranc) Sprain in a Female College Soccer Athlete and Foot Rehabilitation
Park B*, Nicola M*, Wilkins S*: *University of Nebraska at Omaha, Omaha, NE
Objective: To emphasize the importance of the correct treatment protocol and the proper rehabilitation exercises based on the patient’s injury condition and healing process. Background: A 22-year-old female division I soccer athlete underwent tarsometatarsal ligament repair to stabilize midfoot. The patient started feeling pain in the dorsal aspect of her left 1st and 2nd metatarsals at the beginning of the season, however, she reported no specific mechanism of injury ...
Transcriptome Profiling Of Neovascularized Corneas Reveals Mir-204 As A Multi-Target Biotherapy Deliverable By Raavs, 2018 University of Massachusetts Medical School
Transcriptome Profiling Of Neovascularized Corneas Reveals Mir-204 As A Multi-Target Biotherapy Deliverable By Raavs, Yi Lu, Phillip W. L. Tai, Jianzhong Ai, Dominic J. Gessler, Qin Su, Xieyi Yao, Qiang Zheng, Phillip D. Zamore, Xun Xu, Guangping Gao
Open Access Articles
Corneal neovascularization (NV) is the major sight-threatening pathology caused by angiogenic stimuli. Current drugs that directly target pro-angiogenic factors to inhibit or reverse the disease require multiple rounds of administration and have limited efficacies. Here, we identify potential anti-angiogenic corneal microRNAs (miRNAs) and demonstrate a framework that employs discovered miRNAs as biotherapies deliverable by recombinant adeno-associated viruses (rAAVs). By querying differentially expressed miRNAs in neovascularized mouse corneas induced by alkali burn, we have revealed 39 miRNAs that are predicted to target more than 5,500 differentially expressed corneal mRNAs. Among these, we selected miR-204 and assessed its efficacy and therapeutic ...
Editorial: Nucleic Acids Research And Nucleic Acid Therapeutics, 2018 Fred Hutchinson Cancer Research Center, WA
Editorial: Nucleic Acids Research And Nucleic Acid Therapeutics, Barry L. Stoddard, Anastasia Khvorova, David R. Corey, William S. Dynan, Keith R. Fox
RNA Therapeutics Institute Publications
No abstract provided.
The Coding Regions Of Germline Mrnas Confer Sensitivity To Argonaute Regulation In C. Elegans, 2018 University of Massachusetts Medical School
The Coding Regions Of Germline Mrnas Confer Sensitivity To Argonaute Regulation In C. Elegans, Meetu Seth, Masaki Shirayama, Wen Tang, En-Zhi Shen, Shikui Tu, Heng-Chi Lee, Zhiping Weng, Craig C. Mello
RNA Therapeutics Institute Publications
Protein-coding genes undergo a wide array of regulatory interactions with factors that engage non-coding regions. Open reading frames (ORFs), in contrast, are thought to be constrained by coding function, precluding a major role in gene regulation. Here, we explore Piwi-interacting (pi)RNA-mediated transgene silencing in C. elegans and show that marked differences in the sensitivity to piRNA silencing map to the endogenous sequences within transgene ORFs. Artificially increasing piRNA targeting within the ORF of a resistant transgene can lead to a partial yet stable reduction in expression, revealing that piRNAs not only silence but can also "tune" gene expression. Our ...
A Budget Impact Model For Two Investigational Agents For The Treatment Of Nonalcoholic Steatohepatitis, 2018 University of Massachusetts Medical School
A Budget Impact Model For Two Investigational Agents For The Treatment Of Nonalcoholic Steatohepatitis, Nicole M. Trask, Pavel Lavitas, Vincent Palumbo
Commonwealth Medicine Publications
Statistics show approximately 15 million Americans suffer from NASH, a nonalcoholic fatty liver disease that is projected to become the most common reason for liver transplantation. There are no FDA approved therapies for NASH, so doctors are forced to treat patients with off-label medications while keeping an eye out for breakthroughs in medication development.
Two novel therapies, obeticholic acid and elafibranor, are currently in Phase III trials. If they receive FDA approval, interest will be high as they will be the first treatments specifically labeled for NASH. We detail a budget impact model for a sample state Medicaid plan in ...
Impact Of A Pilot Outreach Program Upon Provider Awareness And Prescribing Of A Concerning Opioid Combination Regimen, Briana Santaniello, Thomas C. Pomfret, Mark A. Tesell, Nicole M. Trask, Caroline J. Alper, Karen M. Clements, Vincent Palumbo, Kimberly Lenz, Paul L. Jeffrey
Commonwealth Medicine Publications
This pilot program was developed in response to a drug utilization review within a large Medicaid population that revealed some hazardous practices. Co-prescribing of opioids with benzodiazepines, gabapentin, and other stimulants occurred in more than 500 members, putting them at risk for additive central nervous system depression, misuse, abuse, and death from overdose.
The poster presentation outlines the objectives, methods, and results of a telephonic outreach program that addressed these safety concerns. It captures prescriber awareness of the presence and risks of potentially deadly medication combinations among members in their care, with some intriguing results.
Our experts provide health plans ...
Pof8 Is A La-Related Protein And A Constitutive Component Of Telomerase In Fission Yeast, 2018 Stowers Institute for Medical Research, MO
Pof8 Is A La-Related Protein And A Constitutive Component Of Telomerase In Fission Yeast, Diego J. Paez-Moscoso, Lili Pan, Rutendo F. Sigauke, Morgan R. Schroeder, Wen Tang, Peter Baumann
RNA Therapeutics Institute Publications
Telomerase reverse transcriptase (TERT) and the non-coding telomerase RNA subunit (TR) constitute the core of telomerase. Here we now report that the putative F-box protein Pof8 is also a constitutive component of active telomerase in fission yeast. Pof8 functions in a hierarchical assembly pathway by promoting the binding of the Lsm2-8 complex to telomerase RNA, which in turn promotes binding of the catalytic subunit. Loss of Pof8 reduces TER1 stability, causes a severe assembly defect, and results in critically short telomeres. Structure profile searches identified similarities between Pof8 and telomerase subunits from ciliated protozoa, making Pof8 next to TERT the ...
Antiplatelet Therapy Changes For Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From The Translate-Acs (Treatment With Adp Receptor Inhibitors: Longitudinal Assessment Of Treatment Patterns And Events After Acute Coronary Syndrome) Study, 2018 Duke University
Antiplatelet Therapy Changes For Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From The Translate-Acs (Treatment With Adp Receptor Inhibitors: Longitudinal Assessment Of Treatment Patterns And Events After Acute Coronary Syndrome) Study, Alexander C. Fanaroff, Lisa A. Kaltenbach, Eric D. Peterson, Mohammed W. Akhter, Mark B. Effron, Timothy D. Henry, Tracy Y. Wang
Cardiovascular Medicine Publications and Presentations
BACKGROUND: Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI), yet little guidance is provided on antiplatelet management for patients with recurrent ischemic events during that year. We describe changes in P2Y12 inhibitor type among patients with recurrent ischemic events in the first year after MI.
METHODS AND RESULTS: The TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) study enrolled 12 365 patients with MI treated with percutaneous coronary intervention. We examined whether P2Y12 inhibitor choice changed among patients with recurrent MI, stent thrombosis, and/or unplanned revascularization ...
Hodgkin Lymphoma: Differences In Treatment Between Europe And The United States/North America: Evolving Trends In Protocol Therapy, 2018 University of Massachusetts Medical School
Hodgkin Lymphoma: Differences In Treatment Between Europe And The United States/North America: Evolving Trends In Protocol Therapy, Thomas J. Fitzgerald, Maryann Bishop-Jodoin
Open Access Articles
With continued progress and success in clinical care, the management of patients with Hodgkin lymphoma (HL) has undergone continuous revision to improve patient care outcomes and limit acute and late treatment effects on normal tissue imposed by therapy. Hodgkin lymphoma is a disease that affects children, adolescents, and adults. Clinical management strategies are influenced by the patient's age at diagnosis, tumor burden, response to induction therapy, and potential expectation of treatment impact on normal tissue. The approach to patient management varies in many parts of the world and is influenced by treatment availability, physician training, and medical culture. Differences ...
Impact Of Rituximab On Patient-Reported Outcomes In Patients With Rheumatoid Arthritis From The Us Corrona Registry, 2018 University of Massachusetts Medical School
Impact Of Rituximab On Patient-Reported Outcomes In Patients With Rheumatoid Arthritis From The Us Corrona Registry, Leslie R. Harrold, Ani John, Jennie Best, Steve Zlotnick, Chitra Karki, Youfu Li, Jeffrey D. Greenberg, Joel M. Kremer
Leslie R. Harrold
To evaluate the impact of rituximab on patient-reported outcomes (PROs) in a US-based observational cohort of patients with rheumatoid arthritis (RA). Patients with active RA, prior exposure to > /=1 tumor necrosis factor inhibitor (TNFi) and who newly initiated rituximab were identified. Changes in PROs were assessed 1 year after rituximab initiation. PRO measures included Clinical Disease Activity Index (CDAI); patient global disease activity, pain and fatigue (visual analog score; 0-100); morning stiffness (hours); modified Health Assessment Questionnaire (mHAQ; 0-3); and EuroQoL EQ-5D. Of the 667 patients who newly initiated rituximab, baseline PRO and clinical measures indicated that patients were substantially ...
One-Year Risk Of Serious Infection In Patients Treated With Certolizumab Pegol As Compared With Other Tnf Inhibitors In A Real-World Setting: Data From A National U.S. Rheumatoid Arthritis Registry, 2018 University of Massachusetts Medical School
One-Year Risk Of Serious Infection In Patients Treated With Certolizumab Pegol As Compared With Other Tnf Inhibitors In A Real-World Setting: Data From A National U.S. Rheumatoid Arthritis Registry, Leslie R. Harrold, Heather J. Litman, Katherine C. Saunders, Kimberly J. Dandreo, Bernice Gershenson, Jeffrey D. Greenberg, Robert Low, Jeffrey Stark, Robert Suruki, Srihari Jaganathan, Joel M. Kremer, Mohamed Yassine
Open Access Articles
BACKGROUND: Registry studies provide a valuable source of comparative safety data for tumor necrosis factor inhibitors (TNFi) used in rheumatoid arthritis (RA), but they are subject to channeling bias. Comparing safety outcomes without accounting for channeling bias can lead to inaccurate comparisons between TNFi prescribed at different stages of the disease. In the present study, we examined the incidence of serious infection and other adverse events during certolizumab pegol (CZP) use vs other TNFi in a U.S. RA cohort before and after using a methodological approach to minimize channeling bias.
METHODS: Patients with RA enrolled in the Corrona registry ...
Streamlined Ex Vivo And In Vivo Genome Editing In Mouse Embryos Using Recombinant Adeno-Associated Viruses, 2018 University of Massachusetts Medical School
Streamlined Ex Vivo And In Vivo Genome Editing In Mouse Embryos Using Recombinant Adeno-Associated Viruses, Yeonsoo Yoon, Dan Wang, Phillip W. L. Tai, Joy Riley, Guangping Gao, Jaime A. Rivera-Perez
Pediatric Publications and Presentations
Recent advances using CRISPR-Cas9 approaches have dramatically enhanced the ease for genetic manipulation in rodents. Notwithstanding, the methods to deliver nucleic acids into pre-implantation embryos have hardly changed since the original description of mouse transgenesis more than 30 years ago. Here we report a novel strategy to generate genetically modified mice by transduction of CRISPR-Cas9 components into pre-implantation mouse embryos via recombinant adeno-associated viruses (rAAVs). Using this approach, we efficiently generated a variety of targeted mutations in explanted embryos, including indel events produced by non-homologous end joining and tailored mutations using homology-directed repair. We also achieved gene modification in vivo ...
Gene Therapy Using A Minicep290 Fragment Delays Photoreceptor Degeneration In A Mouse Model Of Leber Congenital Amaurosis, 2018 University of Massachusetts Medical School
Gene Therapy Using A Minicep290 Fragment Delays Photoreceptor Degeneration In A Mouse Model Of Leber Congenital Amaurosis, Wei Zhang, Linjing Li, Qin Su, Guangping Gao, Hemant Khanna
Open Access Articles
Mutations in the cilia-centrosomal protein CEP290 are frequently observed in autosomal recessive childhood blindness disorder Leber congenital amaurosis (LCA). No treatment or cure currently exists for this disorder. The Cep290(rd16) (retinal degeneration 16) mouse (a model of LCA) carries a mutation in the Cep290 gene. This mutation leads to shorter cilia formation and defective photoreceptor structure and function. A roadblock to developing a gene replacement strategy for CEP290 using conventional adeno-associated virus (AAV) vectors is its large size. The identification and characterization is reported of a miniCEP290 gene that is amenable to AAV2/8-mediated delivery and delaying retinal degeneration ...
Survival Advantage Of Both Human Hepatocyte Xenografts And Genome-Edited Hepatocytes For Treatment Of Alpha-1 Antitrypsin Deficiency, 2017 University of Massachusetts Medical School
Survival Advantage Of Both Human Hepatocyte Xenografts And Genome-Edited Hepatocytes For Treatment Of Alpha-1 Antitrypsin Deficiency, Florie Borel, Qiushi Tang, Gwladys Gernoux, Cynthia Greer, Ziqiong Wang, Adi Barzel, Mark A. Kay, Leonard D. Shultz, Dale L. Greiner, Terence R. Flotte, Michael A. Brehm, Christian Mueller
Hepatocytes represent an important target for gene therapy and editing of single-gene disorders. In alpha-1 antitrypsin (AAT) deficiency, one missense mutation results in impaired secretion of AAT. In most patients, lung damage occurs due to a lack of AAT-mediated protection of lung elastin from neutrophil elastase. In some patients, accumulation of misfolded PiZ mutant AAT protein triggers hepatocyte injury, leading to inflammation and cirrhosis. We hypothesized that correcting the Z mutant defect in hepatocytes would confer a selective advantage for repopulation of hepatocytes within an intact liver. A human PiZ allele was crossed onto an immune-deficient (NSG) strain to create ...
Cancer Survivorship: Promoting A Lifetime Of Health, 2017 The University of San Francisco
Cancer Survivorship: Promoting A Lifetime Of Health, Janelle Coleman-Smith
Master's Projects and Capstones
Introduction Cancer survivors can face post-cancer treatment effects that need addressing throughout their care trajectory. Education provided to stakeholders and patients will be beneficial in preventing fragmented care, increasing patient satisfaction, and expanding ongoing supportive clinical survivorship care. Methods An adapted Dr. Joanne Lester survivorship needs survey was given to n=7 post-cancer treatment patients within a northern California cancer patient advisory committee. The survey results were analyzed to identify common underserved chronic long-term survivorship needs. Based on the data, an evidence-based educational component was included within a booklet to enhance future survivorship care. Additional surveys were sent to ...
Structural Determination Of The Broadly Reactive Anti-Ighv1-69 Anti-Idiotypic Antibody G6 And Its Idiotope, 2017 Harvard Medical School
Structural Determination Of The Broadly Reactive Anti-Ighv1-69 Anti-Idiotypic Antibody G6 And Its Idiotope, Yuval Avnir, Kristina L. Prachanronarong, Shurong Hou, Brendan J. Hilbert, Markus-Frederik Bohn, Timothy F. Kowalik, Robert W. Finberg, Jennifer P. Wang, Nese Kurt Yilmaz, Celia A. Schiffer, Wayne A. Marasco
Schiffer Lab Publications
The heavy chain IGHV1-69 germline gene exhibits a high level of polymorphism and shows biased use in protective antibody (Ab) responses to infections and vaccines. It is also highly expressed in several B cell malignancies and autoimmune diseases. G6 is an anti-idiotypic monoclonal Ab that selectively binds to IGHV1-69 heavy chain germline gene 51p1 alleles that have been implicated in these Ab responses and disease processes. Here, we determine the co-crystal structure of humanized G6 (hG6.3) in complex with anti-influenza hemagglutinin stem-directed broadly neutralizing Ab D80. The core of the hG6.3 idiotope is a continuous string of CDR-H2 ...
Metformin And Temozolomide, A Synergic Option To Overcome Resistance In Glioblastoma Multiforme Models, 2017 University of Milan-Bicocca
Metformin And Temozolomide, A Synergic Option To Overcome Resistance In Glioblastoma Multiforme Models, Silvia Valtorta, Alessia Lo. Dico, Isabella Raccagni, Daniela Gaglio, Sara Belloli, Letterio S. Politi, Cristina Martelli, Cecilia Diceglie, Marcella Bonanomi, Giulia Ercoli, Valentina Vaira, Luisa Ottobrini, Rosa Maria Moresco
Radiology Publications and Presentations
Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with poor survival. Cytoreduction in association with radiotherapy and temozolomide (TMZ) is the standard therapy, but response is heterogeneous and life expectancy is limited. The combined use of chemotherapeutic agents with drugs targeting cell metabolism is becoming an interesting therapeutic option for cancer treatment. Here, we found that metformin (MET) enhances TMZ effect on TMZ-sensitive cell line (U251) and overcomes TMZ-resistance in T98G GBM cell line. In particular, combined-treatment modulated apoptosis by increasing Bax/Bcl-2 ratio, and reduced Reactive Oxygen Species (ROS) production. We also observed that MET associated with ...
The Dynamics Of Immunoglobulin V-Gene Usage And Clonotype Expansion In Mice After Prime And Boost Immunizations As Analyzed By Ngs, 2017 University of Massachusetts Medical School
The Dynamics Of Immunoglobulin V-Gene Usage And Clonotype Expansion In Mice After Prime And Boost Immunizations As Analyzed By Ngs, Diego José Farfán Arribas, Shuying Liu, Shixia Wang, Shan Lu
Open Access Articles
In the current study, an improved NGS approach was developed to study the B-cell repertoire evolution in a simple mouse immunization model including only two DNA immunizations. The combination of 5'RACE and Ion Torrent long reads enabled unbiased immunoglobulin repertoire analysis even from small amounts of peripheral mouse blood. The B-cell population expanded by the vaccine displayed a relatively strong clonality. Upon priming with the first vaccine dose, we observed a consistent pattern of V-segment gene and CDR3 usage (public specificities). Interestingly, this pattern diversified with the second dose of immunization -it was relatively different in individual mice in ...